Navigating the Regulatory Maze LB Pharmaceuticals Welcomes Dr. James Rawls as Senior Vice President of Regulatory Aff...
In a strategic move poised to enhance its regulatory prowess, LB Pharmaceuticals Inc. (Nasdaq: LBRX), a forward-thinking biopharmaceutical company focused on developing treatments for neuropsychiatric diseases, has anno...
Oct 14, 2025
Product Service News
